Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC_apceth_101 in Advanced Gastrointestinal Cancer
NCT02008539Phase 2Terminated
- Sponsor
- Apceth Biopharma
- Start
- Oct 2013
- Primary completion
- Sep 2016
- Modality
- Gene Editing, Gene Silencing, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of agenmestencel in gastrointestinal adenocarcinoma (GIAC), sponsored by Apceth Biopharma. Started Oct 2013; status: terminated.
02
Drugs
agenmestencel
03
Conditions
gastrointestinal adenocarcinoma (GIAC)
Beyond the preview
Go deeper on NCT02008539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008539.